Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TNF Pharmaceuticals Inc TNFA

Healthcare
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

Recent & Breaking News (NDAQ:TNFA)

Cannabis (MMJ) Breathalyzer Could Follow Vertical Path of Alcohol Breathalyzer

Accesswire December 2, 2014

RedChip Issues Research Update on Akers Biosciences

GlobeNewswire November 18, 2014

Akers Biosciences Announces Its Financial Results for Third Quarter 2014

GlobeNewswire November 13, 2014

Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results

GlobeNewswire November 10, 2014

Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China

GlobeNewswire October 23, 2014

NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg

GlobeNewswire October 8, 2014

RedChip Announces Presentation Schedule for Its October 15-16 Online Investor Conference

GlobeNewswire October 6, 2014

Akers Biosciences Features on Global Broadcast & Online Media

GlobeNewswire September 16, 2014

Police and Employers May Finally See Cannabis Breathalyzer

Accesswire September 10, 2014

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

GlobeNewswire September 9, 2014

Akers Biosciences Presenting at US Investor Conferences

GlobeNewswire September 9, 2014

Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test

GlobeNewswire September 9, 2014

RedChip Issues Research Update on Akers Biosciences

GlobeNewswire August 18, 2014

Akers Biosciences Reports Its Second Quarter Financial Results

GlobeNewswire August 12, 2014

Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results

GlobeNewswire August 11, 2014

Akers Appoints New Vice President of International Sales and Marketing to Build International Business

GlobeNewswire August 5, 2014

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses

GlobeNewswire July 28, 2014

US Patent Granted for Akers' Breath Ketone Detection Device

GlobeNewswire July 17, 2014

Akers to Ring Today's NASDAQ Closing Bell

GlobeNewswire July 9, 2014

RedChip Announces Schedule for Its July 16-17 Global Online CEO Conference

GlobeNewswire July 8, 2014